CASI Pharmaceuticals Inc — Cash Flow (NASDAQ:CASI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 21.09 M19.97 M29.2 M — Cash from investing activities 31.16 M9.67 M11.24 M — Cash from financing activities 3.27 M907 K15.43 M — Free cash flow 15.48 M17.73 M28.96 M —

News

What Drove CASI Pharmaceuticals' 24% Rise After Hours? - CASI Pharmaceuticals (NASDAQ:CASI)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

CASI Pharmaceuticals stock plunges on Nasdaq delisting notice

Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging Alkermes (ALKS) This Year?

China approves CASI Pharmaceuticals’ CID-103 clinical trial for kidney rejection

CASI Pharmaceuticals stock surges after Nasdaq grants listing extension

Casi Pharmaceuticals secures Nasdaq listing extension until February 2026

CASI Pharmaceuticals secures $20 million funding for transplant rejection study

CASI Pharmaceuticals reports positive phase 1 data for ITP treatment

CASI Pharmaceuticals faces Nasdaq delisting over market value requirement

James Huang to join CASI Pharmaceuticals board as independent director